Treatment Registry
TR-1208 ActiveRecorded November 2026

Compounded tirzepatide

Sold by LumenMeds · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPer monthPublished payment
Monthly subscription — three-month commitment stated in refund policy

The refund policy requires a three-month commitment and says three months of medication are supplied upfront. The homepage FAQ instead says there is no long-term commitment. This is one advertised monthly installment, not a three-month prepaid invoice or a guarantee of the selected bill. Early cancellation is described as a $349.99 fee; confirm which commitment applies before enrolling.

“$191.99”

Per month$191.99Published payment$191.99
Price sources
Visit LumenMeds

We earn nothing from this link. It opens LumenMeds's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • November 2026 — Entry added to the register

Sourcing and terms

Pharmacythe pharmacy assigned to this prescription not disclosed. The Pharmacy Hub is listed as a partner; no pharmacy is assigned to an individual prescription here.
Statesthe medication-specific eligible state roster not disclosed. The doctor network is advertised as licensed in all 50 states; that does not establish individual medication eligibility.
Prescriberthe required consultation format for this program not disclosed. The general consent permits video, phone and asynchronous care; no selected program format is established.
CancellationThe homepage FAQ says cancellation before the next bill ends charges without a long-term commitment. The refund policy instead requires three months and lists a $349.99 early-cancellation fee. It also specifies a $99 deduction for successful pre-intake cancellation, no cancellation refunds after intake, and a full refund without that deduction for medical rejection. Confirm which terms apply before paying.
MembershipNone. “No membership fees.”
Consult feeIncluded in program price; confirm the itemized fee. A doctor visit and ongoing support are advertised within the program; a standalone consultation fee is not itemized.

Recorded from lumenmeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. November 2026 — The homepage FAQ says the monthly subscription includes provider consultations, prescription management, medication and shipping. It says there are no membership fees. Labs may be ordered if needed, but their price or inclusion is not specified. lumenmeds.com
  2. 2. November 2026 — The refund policy describes monthly recurring payments and a three-month commitment for semaglutide and tirzepatide, with three months of medication supplied upfront. The homepage FAQ instead promises no long-term commitment and no further charge when canceled before the next billing date. These statements conflict; confirm the applicable commitment before enrolling. Monthly installments do not establish a three-month prepaid invoice. rrp lumenmeds.com
  3. 3. November 2026 — Cancellation is requested through the secure account and is not guaranteed after ordering. A successful cancellation before medical intake receives a refund less a $99 administration fee; after intake, cancellations are ineligible for refunds. The policy separately promises a full refund without that fee if the doctor rejects the prescription. It also retains the early-cancellation provision for an unfinished three-month commitment. Confirm the applicable amount before paying. rrp
  4. 4. November 2026 — The policy also says medication is nonrefundable once approved and processed by the pharmacy, and fulfilled orders cannot be refunded. Lost-in-transit packages are described as eligible for reshipment; shipping problems or dispensing errors should be reported to support. These are separate from a change-of-mind cancellation. rrp shipping
  5. 5. November 2026 — The partner page names The Pharmacy Hub and MD Integrations. Its all-50-state statement describes the doctor network, not a medication-specific eligibility roster or an assigned pharmacy. The terms allow a pharmacy of the patient’s choosing, requested before ordering; they do not establish what that choice would cost. partner terms
  6. 6. November 2026 — The consent names MD Integrations LLC and Qualiphy PC and permits video, phone and asynchronous consultations. It does not establish the format required for a particular program or patient. Care and prescribing decisions belong to independent providers; payment does not guarantee a prescription. The terms require users to be at least 18 and separately address a parent or legal guardian acting for a minor; this is not a medication-specific eligibility rule. telehealth consent terms
  7. 7. November 2026 — The homepage FAQ estimates shipment usually within 2–3 business days after prescription approval. The separate shipping policy describes processing typically within one business day after approval and pharmacy release, followed by next-business-day delivery, excluding weekends and holidays. The homepage includes shipping, while the shipping policy says costs are included or disclosed at checkout. These estimates do not guarantee an arrival date. lumenmeds.com shipping
  8. 8. November 2026 — The homepage FAQ says most insurance plans do not cover compounded GLP-1 weight-loss medication. The terms say the services are not insurance and prohibit submitting telemedicine charges to Medicare or other public or private payors. These statements do not determine coverage or reimbursement for an individual purchase. lumenmeds.com terms
  9. 9. November 2026 — The website privacy notices discuss marketing, advertising networks, service providers and discount-card services; the California notice says personal information is not sold. The separate HIPAA notice requires written authorization for marketing uses or sale of protected health information. The privacy text also mentions Manifest Pharmacy, which does not establish a dispensing-pharmacy assignment. These are published policies, not an independent privacy audit or evidence of how an individual patient’s information was handled. privacy ccpa hipaa
  10. 10. November 2026 — The homepage advertises compounded tirzepatide with B6. This additive is part of the described option, not a separate GLP-1 ingredient or a proven benefit. The public text reviewed here does not establish an injection route, vial or pen. lumenmeds.com
  11. 11. November 2026 — For compounded tirzepatide, the homepage advertises $191.99 per month. The refund policy separately lists a full retail monthly price of $349.99 and an early-cancellation fee equal to that retail amount for leaving before the three-month commitment ends. The retail figure is not represented as a scheduled renewal price. The selected invoice and applicable cancellation terms remain to be confirmed. lumenmeds.com rrp
  12. 12. November 2026 — The homepage states that its compounded formulations are not FDA-approved. Its FAQ describes partner pharmacies as U.S.-based 503A or 503B facilities and makes testing and inspection claims; these statements have not been independently verified and do not identify the pharmacy assigned to a prescription. Brand names in the general disclaimer do not establish a separate branded program. lumenmeds.com

2 further notes concern other LumenMeds programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-1208
Medication category
compounded tirzepatide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). LumenMeds — compounded tirzepatide (TR-1208). Last verified November 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-1208

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.